解析に用いた抗がん剤(薬剤)の入手先、溶媒、標的分子、用いた処理濃度等のリスト
Chem_id | Compound | Cell | Manufacturer | Solvent | Target/mode of action | Concentration for treatment |
C001 | 2-Deoxyglucose | HT29 | Sigma | distilled water | glycolysis | 10mM |
C002 | Tunicamycin | HT29 | Nacalai Tesque (Kyoto, Japan) | DMSO | N-glycosylation | 3μg/ml |
C003 | Thapsigargin | HT29 | Wako Pure Chemical Industries | DMSO | SERCA | 10nM |
C004 | A23187 | HT29 | Wako Pure Chemical Industries | DMSO | Ca2+ ionophore | 3μM |
C005 | Cisplatin | HT29 | Bristol-Myers Squibb | DMSO | DNA cross-linker | 30μM |
C006 | Trichostatin A | HT29 | Wako Pure Chemical Industries | DMSO | HDAC | 300nM |
C007 | Vorinostat | HT29 | Cayman Chemical Company (Ann Arbor, MI, US) | DMSO | HDAC | 10μM |
C008 | Bortezomib | HT29 | Millennium Pharmaceuticals Inc (Cambridge, MA, US) | DMSO | proteasome | 100nM |
C009 | MG-132 | HT29 | Peptide Institute (Osaka, Japan) | DMSO | proteasome | 1μM |
C010 | Geldanamycin | HT29 | Sigma | DMSO | Hsp90 | 30nM |
C011 | 17-AAG | HT29 | Wako Pure Chemical Industries | DMSO | Hsp90 | 100nM |
C012 | Vincristine | HT29 | Eli Lilly (Indianapolis, IN, US) | distilled water | tubulin | 30nM |
C013 | Paclitaxel | HT29 | Bristo-Myers Squibb (New York, NY, US) | DMSO | tubulin | 30nM |
C014 | Docetaxel | HT29 | Astra Zeneca, Inc (London, UK) | DMSO | tubulin | 30nM |
C015 | 5-FU | HT29 | Sigma | DMSO | Pyrimidine | 100μM |
C016 | Gemicitabine | HT29 | Eli Lilly | Saline | Pyrimidine | 1μM |
C017 | Melphalan | HT29 | Sigma | 75%DMSO | DNA cross-linker | 100μM |
C018 | Mitomycin C | HT29 | Sigma | 50%DMSO | DNA alkylator | 10μM |
C019 | Oxaliplatin | HT29 | Yakult Co.Ltd., | DMSO | DNA cross-linker | 3μM |
C020 | Bleomycin | HT29 | Sigma | distilled water | DNA cleavage? | 30μg/ml |
C021 | Actinomycin D | HT29 | Sigma | DMSO | DNA replication/RNA synthesis | 30nM |
C022 | Neocarzinostatin | HT29 | Sigma | - | DNA cleavage? | 3μg/ml |
C023 | Methotrexate | HT29 | Sigma | DMSO | DHFR | 1μM |
C024 | 6-Mercaptopurine | HT29 | Sigma | DMSO | Purine | 100μM |
C025 | Temsirolimus | HT29 | Santa Cruz Biotechnology (Santa Cruz, CA, US) | DMSO | mTOR | 10μM |
C026 | Everolimus | HT29 | Sigma | DMSO | mTOR | 10μM |
C027 | PP242 | HT29 | Sigma | DMSO | mTOR | 10μM |
C028 | Nimustine | HT29 | Sigma | distilled water | DNA alkylator | 1mM |
C029 | SN-38 | HT29 | Yakult Co.Ltd., (Tokyo Japan) | DMSO | Topoisomerase I | 1μM |
C030 | Camptothecin | HT29 | Sigma | DMSO | Topoisomerase I inhibitor | 3μM |
C031 | Topotecan | HT29 | Sigma | DMSO | Topoisomerase I inhibitor | 3μM |
C032 | Doxorubicin | HT29 | Sigma (St Louis, MO, US) | DMSO | DNA intercalator/TopoisomoeraseⅡ | 1μM |
C033 | Etoposide | HT29 | Bristol-Myers Squibb | DMSO | Topoisomerase II inhibitor | 30μM |
C034 | Mitoxantrone | HT29 | Sigma | DMSO | DNA intercalator/Topoisomerase II | 3μM |
C035 | Pemetrexed | HT29 | Santa Cruz Biotechnology | DMSO | DNA/RNA synthesis | 1μM |
C036 | Sorafenib | HT29 | Selleckchem | DMSO | VEGFR, PDGFR, Raf etc | 10μM |
C037 | Sorafenib | HT29 | Selleckchem | DMSO | VEGFR, PDGFR, Raf etc | 10μM |
C038 | Sunitinib | HT29 | Selleckchem | DMSO, - | VEGFR, PDGFR etc | 10μM |
C039 | Sunitinib | HT29 | Selleckchem | DMSO, - | VEGFR, PDGFR etc | 10μM |
C040 | Lapatinib | HT29 | Cell Signaling Technology | DMSO | EGFR/Her2 | 30μM |
C041 | Lapatinib | HT29 | Cell Signaling Technology | DMSO | EGFR/Her2 | 100μM |
C042 | Dasatinib | HT29 | Cell Signaling Technology (Danvers, MA, US) | DMSO | Bcr-Abl/Src | 2nM |
C043 | Erlotinib | HT29 | Cell Signaling Technology | DMSO | EGFR | 30μM |
C044 | Gefitinib | HT29 | Wako Pure Chemical Industries (Osaka, Japan) | DMSO | EGFR | 10μM |
C045 | Gefitinib | HT29 | Wako Pure Chemical Industries (Osaka, Japan) | DMSO | EGFR | 30μM |
C046 | Pazopanib | HT29 | Selleckchem? | DMSO | VEGFR, KIT, FGFR,PDGFR etc | 30μM |
C047 | Vorinostat | HT29 | Cayman Chemical Company (Ann Arbor, MI, US) | DMSO | HDAC | 10μM |
C048 | Bortezomib | HT29 | Millennium Pharmaceuticals Inc (Cambridge, MA, US) | DMSO | proteasome | 100nM |
C049 | Geldanamycin | HT29 | Sigma | DMSO | Hsp90 | 30nM |
C050 | 17-AAG | HT29 | Wako Pure Chemical Industries | DMSO | Hsp90 | 100nM |
C051 | Vincristine | HT29 | Eli Lilly (Indianapolis, IN, US | distilled water | tubulin | 30nM |
C052 | Paclitaxel | HT29 | Bristo-Myers Squibb (New York, NY, US) | DMSO | tubulin | 30nM |
C053 | Docetaxel | HT29 | Astra Zeneca, Inc (London, UK) | DMSO | tubulin | 30nM |
C054 | 5-FU | HT29 | Sigma | DMSO | Pyrimidine | 100μM |
C055 | Mitomycin C | HT29 | Sigma | 50%DMSO | DNA alkylator | 10μM |
C056 | Vorinostat | HT29 | Cayman Chemical Company (Ann Arbor, MI, US) | DMSO | HDAC | 10μM |
C057 | Bortezomib | HT29 | Millennium Pharmaceuticals Inc (Cambridge, MA, US) | DMSO | proteasome | 100nM |
C058 | Vorinostat | HT29 | Cayman Chemical Company (Ann Arbor, MI, US) | DMSO | HDAC | 10μM |
C059 | Bortezomib | HT29 | Millennium Pharmaceuticals Inc (Cambridge, MA, US) | DMSO | proteasome | 100nM |
C060 | Gemicitabine | HT29 | Eli Lilly | Saline | Pyrimidine | 1μM |
C061 | Oxaliplatin | HT29 | Yakult Co.Ltd., | DMSO | DNA cross-linker | 3μM |
C062 | Bleomycin | HT29 | Sigma | distilled water | DNA cleavage | 30μg/ml |
C063 | Neocarzinostatin | HT29 | Sigma | - | DNA cleavage | 3μg/ml |
C064 | Methotrexate | HT29 | Sigma | DMSO | DHFR | 1μM |
C065 | 6-Mercaptopurine | HT29 | Sigma | DMSO | Purine | 100μM |
C066 | Temsirolimus | HT29 | Santa Cruz Biotechnology (Santa Cruz, CA, US) | DMSO | mTOR | 10μM |
C067 | Everolimus | HT29 | Sigma | DMSO | mTOR | 10μM |
C068 | PP242 | HT29 | Sigma | DMSO | mTOR | 10μM |
C069 | Etoposide | HT29 | Bristol-Myers Squibb | DMSO | Topoisomerase II inhibitor | 30μM |
C070 | Pemetrexed | HT29 | Santa Cruz Biotechnology | DMSO | DNA/RNA synthesis | 1μM |
C071 | Amrubicin | HT29 | Santa Cruz Biotechnology | DMSO | Topoisomerase II inhibitor | 10μM |
C072 | MLN-4924 | HT29 | Active Biochem (Hong Kong, Chin) | DMSO | Nedd8 activating enzyme | 10μM |
C073 | Akt Inhibitor VIII | HT29 | Calbio Chem (San Diego, CA, US) | DMSO | Akt 1/2 | 10μM |
C074 | ATM/ATR kinase inhibitor | HT29 | Calbio Chem | DMSO | ATM,ATR | 10μM |
C075 | Cdk4 inhibitor | HT29 | Calbio Chem | DMSO | CDK4 | 10μM |
C076 | SB218078 | HT29 | Calbio Chem | DMSO | Chk1 | 3μM |
C077 | Chk2 inhibitor II | HT29 | Calbio Chem | DMSO | Chk2 | 100μM |
C078 | GSK-3 inhibitor IX | HT29 | Calbio Chem | DMSO | GSK-3 | 10μM |
C079 | 5-Aza-2'-deoxycytidine | HT29 | Wako Pure Chemical Industries | DMSO | DNA methyltransferase | 100μM |
C080 | FH535 | HT29 | Calbio Chem | DMSO | beta-catenin/Tcf | 30μM |
C081 | BI 2536 | HT29 | Selleckchem | DMSO | Polo-like kinase | 10nM |
C082 | Aurora kinase inhibitor III | HT29 | Calbio Chem | DMSO | Aurora kinase | 10μM |
C083 | NU6102 | HT29 | Calbio Chem | DMSO | cdk1/cyclinB | 30μM |
C084 | TX-1918 | HT29 | Calbio Chem | DMSO | eukaryotic elongation factor-2 kinase (eEF2K) | 10μM |
C085 | AG1024 | HT29 | Calbio Chem | DMSO | IGF1R | 30μM |
C086 | U-0126 | HT29 | Wako Pure Chemical Industries | DMSO | MEK | 30μM |
C087 | SU11274 | HT29 | Calbio Chem | DMSO | MET | 30μM |
C088 | PDGFR inhibitor V | HT29 | Calbio Chem | DMSO | PDGFR | 10μM |
C089 | PKR inhibitor | HT29 | Calbio Chem | DMSO | RNA-dependent protein kinase (PKR) | 3μM |
C090 | Decitabine | HT29 | Selleckchem | DMSO | DNA methyltransferase | 100μM |
C091 | Romidepsin | HT29 | Selleckchem | DMSO | HDAC | 3nM |
C092 | Vandetanib | HT29 | Selleckchem | DMSO | VEGFR, EGFR etc | 10μM |
C093 | Vemurafenib | HT29 | Selleckchem | DMSO | BRAF(V600E) | 30μM |
C094 | Crizotinib | HT29 | Selleckchem | DMSO | ALK | 10μM |
C095 | Ruxolitinib | HT29 | Selleckchem | DMSO | JAK | 100μM |
C096 | Axitinib | HT29 | Selleckchem | DMSO | VEGFR, KIT, PDGFR etc | 100μM |
C097 | Vismodegib | HT29 | Selleckchem | DMSO | SMO | 100μM |
C098 | Carfilzomib | HT29 | Selleckchem | DMSO | proteasome | 10nM |
C099 | Regorafenib | HT29 | Selleckchem | DMSO | VEGFR, KIT, RET, Raf etc | 30μM |
C100 | Cabozantinib | HT29 | Selleckchem | DMSO | VEGFR, MET,Ret,KIT,Flt1/3/4 etc | 30μM |
C101 | SN-38 | SKOV3 | Yakult Co.Ltd., (Tokyo Japan) | DMSO | Topoisomerase I | 1μM |
C102 | Doxorubicin | SKOV3 | Sigma (St Louis, MO, US) | DMSO | DNA intercalator/Topoisomoerase II | 1μM |
C103 | Lapatinib | SKOV3 | Cell Signaling Technology | DMSO | EGFR/Her2 | 30μM |
C104 | SN-38 | K562 | Yakult Co.Ltd., (Tokyo Japan) | DMSO | TopoisomeraseⅠ | 1μM |
C105 | Doxorubicin | K562 | Sigma (St Louis, MO, US | DMSO | DNA intercalator/Topoisomoerase II | 1μM |
C106 | Imatinib | K562 | Selleckchem (Houston, TX, US) | DMSO | Bcr-Abl/KIT | 0.6μM |
C107 | Bosutinib | K562 | Selleckchem | DMSO | Bcr-Abl/Src | 200nM |
C108 | Dasatinib | K562 | Cell Signaling Technology (Danvers, MA, US) | DMSO | Bcr-Abl/Src | 2nM |
C109 | Nilotinib | K562 | Selleckchem | DMSO | Bcr-Abl | 20nM |
C110 | Ponatinib | K562 | Selleckchem | DMSO | Bcr-Abl(T315I) | 6nM |
C111 | SN-38 | PC-9 | Yakult Co.Ltd., (Tokyo Japan) | DMSO | TopoisomeraseⅠ | 1μM |
C112 | Doxorubicin | PC-9 | Sigma (St Louis, MO, US | DMSO | DNA intercalator/Topoisomoerase II | 1μM |
C113 | Erlotinib | PC-9 | Cell Signaling Technology | DMSO | EGFR | 0.6μM |
C114 | Erlotinib | PC-9 | Cell Signaling Technology | DMSO | EGFR | 30μM |
C115 | Gefitinib | PC-9 | Wako Pure Chemical Industries (Osaka, Japan) | DMSO | EGFR | 0.6μM |
C116 | Gefitinib | PC-9 | Wako Pure Chemical Industries (Osaka, Japan) | DMSO | EGFR | 30μM |
C117 | Alectinib/CH5424802 | HT29 | Selleckchem | DMSO | ALK | 10μM |
C118 | Celecoxib | HT29 | Selleckchem | DMSO | COX2 | 100μM |
C119 | BKM120 | HT29 | Selleckchem | DMSO | PI3K | 3μM |
C120 | BEZ235 | HT29 | Santa Cruz Biotechnology | DMSO | PI3K/mTOR | 1μM |
C121 | Dabrafenib | HT29 | Selleckchem | DMSO | BRAF(V600E) | 10μM |
C122 | Trametinib | HT29 | Selleckchem | DMSO | MEK | 1μM |
C123 | Afatinib | HT29 | Selleckchem | DMSO | EGFR/Her2 | 30nM |
C124 | Afatinib | PC-9 | Selleckchem | DMSO | EGFR/Her2 | 30nM |
C125 | Trametinib | PC-9 | Selleckchem | DMSO | MEK | 1μM |
C126 | Crizotinib | H2228 | Selleckchem | DMSO | ALK | 10μM |
C127 | Alectinib/CH5424802 | H2228 | Selleckchem | DMSO | ALK | 10μM |
C128 | SN38 | H2228 | Yakult Co.Ltd., | DMSO | TopoisomeraseⅠ | 3μM |
C129 | Doxorubicin | H2228 | Sigma (St Louis, MO, US) | DMSO | DNA intercalator/Topoisomoerase II | 1μM |